<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38274806</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>A viral-specific CD4<sup>+</sup> T cell response protects female mice from Coxsackievirus B3 infection.</ArticleTitle><Pagination><StartPage>1327384</StartPage><MedlinePgn>1327384</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1327384</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1327384</ELocationID><Abstract><AbstractText Label="BACKGROUND">Biological sex plays an integral role in the immune response to various pathogens. The underlying basis for these sex differences is still not well defined. Here, we show that Coxsackievirus B3 (CVB3) induces a viral-specific CD4+ T cell response that can protect female mice from mortality.</AbstractText><AbstractText Label="METHODS">We inoculated C57BL/6 Ifnar<sup>-/-</sup> mice with CVB3. We investigated the T cell response in the spleen and mesenteric lymph nodes in male and female mice following infection.</AbstractText><AbstractText Label="RESULTS">We found that CVB3 can induce expansion of CD62Llo CD4+ T cells in the mesenteric lymph node and spleen of female but not male mice as early as 5 days post-inoculation, indicative of activation. Using a recombinant CVB3 virus expressing a model CD4+ T cell epitope, we found that this response is due to viral antigen and not bystander activation. Finally, the depletion of CD4+ T cells before infection increased mortality in female mice, indicating that CD4+ T cells play a protective role against CVB3 in our model.</AbstractText><AbstractText Label="CONCLUSIONS">Overall, these data demonstrated that CVB3 can induce an early CD4 response in female but not male mice and further emphasize how sex differences in immune responses to pathogens affect disease.</AbstractText><CopyrightInformation>Copyright © 2024 Pattnaik, Dhalech, Condotta, Corn, Richer, Snell and Robinson.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pattnaik</LastName><ForeName>Aryamav</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dhalech</LastName><ForeName>Adeeba H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Condotta</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corn</LastName><ForeName>Caleb</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richer</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snell</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 DK110216</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92020D00005</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N99020D00005</GrantID><Acronym>OF</Acronym><Agency>ORFDO NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 DK106846</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 DK124749</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N95020D00005</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93023D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93022D00005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA082709</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Oct 27:2023.10.24.563774. doi: 10.1101/2023.10.24.563774</RefSource><PMID Version="1">37961130</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD4 T cells</Keyword><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">Enteric virus</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword><Keyword MajorTopicYN="N">viral clearance</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38274806</ArticleId><ArticleId IdType="pmc">PMC10808549</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1327384</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PloS Pathog (2016) 12:e1005374. doi: 10.1371/journal.ppat.1005374</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005374</ArticleId><ArticleId IdType="pmc">PMC4759457</ArticleId><ArticleId IdType="pubmed">26891052</ArticleId></ArticleIdList></Reference><Reference><Citation>Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol (2014) 35:97–104. doi: 10.1016/j.it.2013.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.10.006</ArticleId><ArticleId IdType="pubmed">24239225</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol (2019) 41:239–49. doi: 10.1007/s00281-018-0726-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0726-5</ArticleId><ArticleId IdType="pmc">PMC6373179</ArticleId><ArticleId IdType="pubmed">30547182</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y, et al. . Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proc Natl Acad Sci U.S.A. (2021) 118(33):e2023216118. doi: 10.1073/pnas.2023216118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2023216118</ArticleId><ArticleId IdType="pmc">PMC8379935</ArticleId><ArticleId IdType="pubmed">34385315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujantell M, Altfeld M. Consequences of sex differences in Type I IFN responses for the regulation of antiviral immunity. Front Immunol (2022) 13:986840. doi: 10.3389/fimmu.2022.986840</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.986840</ArticleId><ArticleId IdType="pmc">PMC9522975</ArticleId><ArticleId IdType="pubmed">36189206</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd KC, Menon M. Sex bias in lymphocytes: Implications for autoimmune diseases. Front Immunol (2022) 13:945762. doi: 10.3389/fimmu.2022.945762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.945762</ArticleId><ArticleId IdType="pmc">PMC9730535</ArticleId><ArticleId IdType="pubmed">36505451</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol (1984) 132:656–61. doi: 10.4049/jimmunol.132.2.656</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.132.2.656</ArticleId><ArticleId IdType="pubmed">6228595</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. . Infectious disease in an era of global change. Nat Rev Microbiol (2022) 20:193–205. doi: 10.1038/s41579-021-00639-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00639-z</ArticleId><ArticleId IdType="pmc">PMC8513385</ArticleId><ArticleId IdType="pubmed">34646006</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundamraj V, Hasbun R. Viral meningitis and encephalitis: an update. Curr Opin Infect Dis (2023) 36:177–85. doi: 10.1097/QCO.0000000000000922</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000922</ArticleId><ArticleId IdType="pubmed">37093042</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao X, Liu X, Wang Y, Li Y, Wang L, Yang Q, et al. . Analysis of the epidemiological trends of enterovirus A in Asia and Europe. J Infect Chemother (2023) 29:316–21. doi: 10.1016/j.jiac.2022.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.12.006</ArticleId><ArticleId IdType="pubmed">36528275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L, Moreni G, Wolthers KC, Pajkrt D. World-wide prevalence and genotype distribution of enteroviruses. Viruses (2021) 13(3):434. doi: 10.3390/v13030434</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030434</ArticleId><ArticleId IdType="pmc">PMC7999254</ArticleId><ArticleId IdType="pubmed">33800518</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrinath A, Bhatta S, Kloc A. Persistent viral infections and their role in heart disease. Front Microbiol (2022) 13:1030440. doi: 10.3389/fmicb.2022.1030440</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1030440</ArticleId><ArticleId IdType="pmc">PMC9730422</ArticleId><ArticleId IdType="pubmed">36504781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BE, Davies HD. Aseptic meningitis. Curr Opin Infect Dis (2007) 20:272–7. doi: 10.1097/QCO.0b013e3280ad4672</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e3280ad4672</ArticleId><ArticleId IdType="pubmed">17471037</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Beetler DJ, Musigk N, Heidecker B, Lyle MA, Cooper LT , Jr., et al. . Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Front Cardiovasc Med (2023) 10:1129348. doi: 10.3389/fcvm.2023.1129348</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1129348</ArticleId><ArticleId IdType="pmc">PMC10017519</ArticleId><ArticleId IdType="pubmed">36937911</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med (2000) 6:693–7. doi: 10.1038/76277</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76277</ArticleId><ArticleId IdType="pubmed">10835688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods (2007) 41:118–22. doi: 10.1016/j.ymeth.2006.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.07.009</ArticleId><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol (2001) 75:2377–87. doi: 10.1128/JVI.75.5.2377-2387.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.5.2377-2387.2001</ArticleId><ArticleId IdType="pmc">PMC114821</ArticleId><ArticleId IdType="pubmed">11160741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol (1994) 68:5126–32. doi: 10.1128/jvi.68.8.5126-5132.1994</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.8.5126-5132.1994</ArticleId><ArticleId IdType="pmc">PMC236456</ArticleId><ArticleId IdType="pubmed">8035512</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol (1995) 69:6720–8. doi: 10.1128/jvi.69.11.6720-6728.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.11.6720-6728.1995</ArticleId><ArticleId IdType="pmc">PMC189582</ArticleId><ArticleId IdType="pubmed">7474082</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Kupperman J, Newell MK. Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in mice. J Virol (1999) 73:4689–95. doi: 10.1128/JVI.73.6.4689-4695.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.6.4689-4695.1999</ArticleId><ArticleId IdType="pmc">PMC112510</ArticleId><ArticleId IdType="pubmed">10233928</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, et al. . Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun (2009) 23:649–57. doi: 10.1016/j.bbi.2008.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2008.12.002</ArticleId><ArticleId IdType="pmc">PMC3148833</ArticleId><ArticleId IdType="pubmed">19126426</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Sartini D, Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol (2002) 76:10785–90. doi: 10.1128/JVI.76.21.10785-10790.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.21.10785-10790.2002</ArticleId><ArticleId IdType="pmc">PMC136647</ArticleId><ArticleId IdType="pubmed">12368321</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Moraska A, Choate M. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis. J Virol (1992) 66:6541–6. doi: 10.1128/jvi.66.11.6541-6546.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.66.11.6541-6546.1992</ArticleId><ArticleId IdType="pmc">PMC240148</ArticleId><ArticleId IdType="pubmed">1328680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Shi C, Budd RC. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol (2002) 76:6487–94. doi: 10.1128/JVI.76.13.6487-6494.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.13.6487-6494.2002</ArticleId><ArticleId IdType="pmc">PMC136276</ArticleId><ArticleId IdType="pubmed">12050361</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Stone JE, Wagner DH, Jr., Kupperman J, Pfeiffer L, David C, et al. . gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J Virol (1999) 73:5630–6. doi: 10.1128/JVI.73.7.5630-5636.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.7.5630-5636.1999</ArticleId><ArticleId IdType="pmc">PMC112621</ArticleId><ArticleId IdType="pubmed">10364312</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Wang Y, Pfeiffer JK. Sex-dependent intestinal replication of an enteric virus. J Virol (2017) 91(7):e02101-16. doi: 10.1128/JVI.02101-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02101-16</ArticleId><ArticleId IdType="pmc">PMC5355612</ArticleId><ArticleId IdType="pubmed">28100612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalech AH, Corn CM, Mangale V, Syed F, Condotta SA, Richer MJ, et al. . Testosterone promotes the intestinal replication and dissemination of coxsackievirus B3 in an oral inoculation mouse model. J Virol (2022) 96:e0123222. doi: 10.1128/jvi.01232-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01232-22</ArticleId><ArticleId IdType="pmc">PMC9472648</ArticleId><ArticleId IdType="pubmed">36037480</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Job LP, Auld KR. Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c mice. Cell Immunol (1982) 67:173–9. doi: 10.1016/0008-8749(82)90210-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-8749(82)90210-6</ArticleId><ArticleId IdType="pubmed">6280880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyden DC, Olszewski J, Feran M, Job LP, Huber SA. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol (1987) 126:432–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899641</ArticleId><ArticleId IdType="pubmed">3030117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalech AH, Condotta SA, Pattnaik A, Corn C, Richer MJ, Robinson CM. Coxsackievirus B3 elicits a sex-specific CD8+ T cell response which protects female mice. PloS Pathog (2023) 19:e1011465. doi: 10.1371/journal.ppat.1011465</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011465</ArticleId><ArticleId IdType="pmc">PMC10503745</ArticleId><ArticleId IdType="pubmed">37669302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, et al. . The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol (2005) 79:4460–9. doi: 10.1128/JVI.79.7.4460-4469.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S, Igarashi H, Nagata N, Sakai M, Koike S, Nochi T, et al. . Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol (2007) 81:7902–12. doi: 10.1128/JVI.02675-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02675-06</ArticleId><ArticleId IdType="pmc">PMC1951287</ArticleId><ArticleId IdType="pubmed">17507470</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol (1998) 28:390–400. doi: 10.1002/(SICI)1521-4141(199801)28:01&lt;390::AID-IMMU390&gt;3.0.CO;2-O</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-4141(199801)28:01&lt;390::AID-IMMU390&gt;3.0.CO;2-O</ArticleId><ArticleId IdType="pubmed">9485218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D, Pham NL, Harty JT, Badovinac VP. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol (2009) 183:7672–81. doi: 10.4049/jimmunol.0902874</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902874</ArticleId><ArticleId IdType="pmc">PMC2808048</ArticleId><ArticleId IdType="pubmed">19933864</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlub TE, Badovinac VP, Sabel JT, Harty JT, Davenport MP. Predicting CD62L expression during the CD8+ T-cell response in vivo . Immunol Cell Biol (2010) 88:157–64. doi: 10.1038/icb.2009.80</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2009.80</ArticleId><ArticleId IdType="pmc">PMC2824781</ArticleId><ArticleId IdType="pubmed">19859082</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolz JC, Starbeck-Miller GR, Harty JT. Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy (2011) 3:1223–33. doi: 10.2217/imt.11.100</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt.11.100</ArticleId><ArticleId IdType="pmc">PMC3214994</ArticleId><ArticleId IdType="pubmed">21995573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CC, Jensen R, Dailey MO. Mechanisms of L-selectin regulation by activated T cells. J Immunol (1997) 159:1686–94. doi: 10.4049/jimmunol.159.4.1686</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.159.4.1686</ArticleId><ArticleId IdType="pubmed">9257829</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott DS, Varga SM. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J Immunol (2011) 187:5568–76. doi: 10.4049/jimmunol.1102104</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102104</ArticleId><ArticleId IdType="pmc">PMC3221938</ArticleId><ArticleId IdType="pubmed">22043009</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe (2011) 9:451–62. doi: 10.1016/j.chom.2011.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.05.008</ArticleId><ArticleId IdType="pmc">PMC3117254</ArticleId><ArticleId IdType="pubmed">21669394</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, et al. . Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol (2011) 13:188–95. doi: 10.1038/ni.2180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2180</ArticleId><ArticleId IdType="pmc">PMC3262959</ArticleId><ArticleId IdType="pubmed">22157630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura D, Miyakoda M, Kimura K, Honma K, Hara H, Yoshida H, et al. . Interleukin-27-producing CD4(+) T cells regulate protective immunity during malaria parasite infection. Immunity (2016) 44:672–82. doi: 10.1016/j.immuni.2016.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.011</ArticleId><ArticleId IdType="pubmed">26968425</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, Richer MJ. Analysis of the T cell response to zika virus and identification of a novel CD8+ T cell epitope in immunocompetent mice. PloS Pathog (2017) 13:e1006184. doi: 10.1371/journal.ppat.1006184</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006184</ArticleId><ArticleId IdType="pmc">PMC5322871</ArticleId><ArticleId IdType="pubmed">28231312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Harkins S, Whitmire JK, Flynn CT, Feuer R, Whitton JL. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PloS Pathog (2009) 5:e1000618. doi: 10.1371/journal.ppat.1000618</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000618</ArticleId><ArticleId IdType="pmc">PMC2757675</ArticleId><ArticleId IdType="pubmed">19834548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Harkins S, Whitton JL. Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol (2008) 82:4331–42. doi: 10.1128/JVI.02639-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02639-07</ArticleId><ArticleId IdType="pmc">PMC2293035</ArticleId><ArticleId IdType="pubmed">18305030</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiaansen AF, Dixit UG, Coler RN, Marie Beckmann A, Reed SG, Winokur PL, et al. . CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination. Vaccine (2017) 35:4255–61. doi: 10.1016/j.vaccine.2017.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.06.013</ArticleId><ArticleId IdType="pmc">PMC5551405</ArticleId><ArticleId IdType="pubmed">28662951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmer RM, Bandala-Sanchez E, Harrison LC. Forward light scatter is a simple measure of T-cell activation and proliferation but is not universally suited for doublet discrimination. Cytometry A (2011) 79:646–52. doi: 10.1002/cyto.a.21096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.21096</ArticleId><ArticleId IdType="pubmed">21695774</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshimi K. Clinical features, pathogenesis, and treatment of large granular lymphocyte leukemias. Intern Med (2017) 56:1759–69. doi: 10.2169/internalmedicine.56.8881</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.56.8881</ArticleId><ArticleId IdType="pmc">PMC5548667</ArticleId><ArticleId IdType="pubmed">28717070</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell LM, Xu W, Abd-Rabbo D, Boukhaled G, Guo M, Macleod BL, et al. . Dynamic CD4(+) T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection. Nat Immunol (2021) 22:1524–37. doi: 10.1038/s41590-021-01060-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01060-7</ArticleId><ArticleId IdType="pmc">PMC10286806</ArticleId><ArticleId IdType="pubmed">34795443</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell LM, Osokine I, Yamada DH, de la Fuente JR, Elsaesser HJ, Brooks DG. Overcoming CD4 th1 cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection. Cell Rep (2016) 16:3286–96. doi: 10.1016/j.celrep.2016.08.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.065</ArticleId><ArticleId IdType="pmc">PMC5669380</ArticleId><ArticleId IdType="pubmed">27653690</ArticleId></ArticleIdList></Reference><Reference><Citation>Umair M, Fazazi MR, Rangachari M. Biological sex as a critical variable in CD4(+) effector T cell function in preclinical models of multiple sclerosis. Antioxid Redox Signal (2022) 37:135–49. doi: 10.1089/ars.2021.0202</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0202</ArticleId><ArticleId IdType="pmc">PMC9293683</ArticleId><ArticleId IdType="pubmed">34538129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahnstedt H, McCullough LD. The impact of sex and age on T cell immunity and ischemic stroke outcomes. Cell Immunol (2019) 345:103960. doi: 10.1016/j.cellimm.2019.103960</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2019.103960</ArticleId><ArticleId IdType="pmc">PMC6832888</ArticleId><ArticleId IdType="pubmed">31519365</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA. Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells. Virology (2008) 378:292–8. doi: 10.1016/j.virol.2008.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.05.015</ArticleId><ArticleId IdType="pmc">PMC2596296</ArticleId><ArticleId IdType="pubmed">18586295</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Badry E, Macharia G, Claiborne D, Brooks K, Dilernia DA, Goepfert P, et al. . Better Viral Control despite Higher CD4(+) T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol. J Virol (2020) 94(16):e00758-20. doi: 10.1128/JVI.00758-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00758-20</ArticleId><ArticleId IdType="pmc">PMC7394904</ArticleId><ArticleId IdType="pubmed">32461316</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpuzoglu E, Phillips RA, Gogal RM, Jr., Ansar Ahmed S. IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12. Mol Immunol (2007) 44:1808–14. doi: 10.1016/j.molimm.2006.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2006.08.005</ArticleId><ArticleId IdType="pmc">PMC3097111</ArticleId><ArticleId IdType="pubmed">17046061</ArticleId></ArticleIdList></Reference><Reference><Citation>Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, et al. . Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol (2003) 33:512–21. doi: 10.1002/immu.200310027</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/immu.200310027</ArticleId><ArticleId IdType="pubmed">12645950</ArticleId></ArticleIdList></Reference><Reference><Citation>Abston ED, Coronado MJ, Bucek A, Bedja D, Shin J, Kim JB, et al. . Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol (2012) 2012:129486. doi: 10.1155/2012/129486</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/129486</ArticleId><ArticleId IdType="pmc">PMC3195533</ArticleId><ArticleId IdType="pubmed">22013485</ArticleId></ArticleIdList></Reference><Reference><Citation>Way SS, Havenar-Daughton C, Kolumam GA, Orgun NN, Murali-Krishna K. IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection. J Immunol (2007) 178:4498–505. doi: 10.4049/jimmunol.178.7.4498</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.7.4498</ArticleId><ArticleId IdType="pmc">PMC2626161</ArticleId><ArticleId IdType="pubmed">17372008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity (2014) 40:367–77. doi: 10.1016/j.immuni.2014.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC3992517</ArticleId><ArticleId IdType="pubmed">24631156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayamada S, Poholek AC, Lu KT, Takahashi H, Kato M, Iwata S, et al. . Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program. J Immunol (2014) 192:2156–66. doi: 10.4049/jimmunol.1300675</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300675</ArticleId><ArticleId IdType="pmc">PMC3967131</ArticleId><ArticleId IdType="pubmed">24489092</ArticleId></ArticleIdList></Reference><Reference><Citation>Osokine I, Snell LM, Cunningham CR, Yamada DH, Wilson EB, Elsaesser HJ, et al. . Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proc Natl Acad Sci U.S.A. (2014) 111:7409–14. doi: 10.1073/pnas.1401662111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401662111</ArticleId><ArticleId IdType="pmc">PMC4034239</ArticleId><ArticleId IdType="pubmed">24799699</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa R, London M, Rezende de Castro TB, Reis B, Buissant des Amorie J, Smith JG, et al. . Newly recruited intraepithelial Ly6A(+)CCR9(+)CD4(+) T cells protect against enteric viral infection. Immunity (2022) 55(7):1234-1249.e6. doi: 10.1016/j.immuni.2022.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.05.001</ArticleId><ArticleId IdType="pmc">PMC9283333</ArticleId><ArticleId IdType="pubmed">35617965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>